Related Articles

• miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway
• Identification of microRNAs involved in gefitinib resistance of non‑small‑cell lung cancer through the insulin‑like growth factor receptor 1 signaling pathway
• miR‑223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin‑like growth factor‑1 receptor and cyclin-dependent kinase 2
• Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines
• Isolation and characterization of erlotinib-resistant human non-small cell lung cancer A549 cells